Oncology Pharma, Inc.

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Biolojic To Use Computational Platform

The stock-market hype is over—but the research and start-up activity is hotter than ever. It may have been the single greatest instance of bio-stock hype since the IPO of Genentech Inc. two decades

Waging a natural war against cancer The quest to develop less toxic cancer therapies has led many to explore the role of angiogenesis, the process by which malignant tumors fuel themselves by creating